[en] OBJECTIVE: To determine and compare antimicrobial susceptibility patterns of pathogenic bacteria from inpatients and outpatients at a university teaching hospital in Yaounde, Cameroon. METHODS: Gram-negative bacilli isolates (n = 522), obtained from a wide range of clinical specimens (urine, pus and blood) from inpatients and outpatients at Yaounde Central Hospital between March 1995 and April 1998, were evaluated for resistance to antibiotics (amoxicillin, amoxicillin/clavulanate, piperacillin, cefazolin, cefoxitin, cefotaxime, ceftazidime, aztreonam, imipenem, gentamicin, tobramicin, ofloxacin and trimethoprim/sulfamethoxazole). RESULTS: Of the 522 isolates recorded, 80.3% were Enterobacteriaceae. A high incidence of resistance to amoxicillin (85%), piperacillin (75%) and trimethoprim/sulfamethoxazole (71%) was observed. The proportion of antimicrobial-resistant isolates from inpatients was significantly higher than that from outpatients (P < 0.05), except for piperacillin, tobramicin and trimethoprim/sulfamethoxazole. The combinations of antimicrobial and organism showed that the percentage of ceftazidime-resistant Pseudomonas aeruginosa and ceftazidime-resistant Enterobacter cloacae were 26.8% and 24% respectively. The rate of antimicrobial resistance in isolates from inpatients was not significantly higher than that in isolates from outpatients for all the antimicrobial/organism combinations, except for ceftazidime-resistant Escherichia coli, which was exclusively found in isolates from inpatients. Among Enterobacteriaceae, high and low level penicillinase (mostly in E. coli (13.6% and 11% respectively) and Klebsiella spp. (9% and 8% respectively) were the most important beta-lactam resistance phenotypes (31.2% and 23.6%, respectively). Wild type (exclusively observed in E. coli, Proteus mirabilis and Salmonella spp.) and low level penicillinase were higher in outpatient than inpatient isolates (wild type--17.9% vs 10.8% and low level penicillinase--29.4% vs 20.5%, respectively; P < 0.05). However, extended spectrum beta-lactamase strains (Klebsiella spp. (3.5%), E. coli (2.6%), Citrobacter spp. (0.7%), Enterobacter spp. (0.4%) and P. mirabilis (0.2%)) were exclusively recovered from inpatients. Penicillinase and high level cephalosporinase resistance phenotypes were frequently observed in non-fermenter Gram-negative bacilli (46.6% and 29.1% respectively). However, there were no significant differences in penicillinase and cephalosporinase resistance between inpatient and outpatient isolates. CONCLUSION: As the incidence of antimicrobial resistance is substantially higher in isolates from inpatient than outpatient pathogens, more resources should be allocated within the hospital to encourage good antibiotic practices and good hospital hygiene.
Disciplines :
Microbiology
Author, co-author :
Gangoue Pieboji, Joseph ; Institut de Recherches médicales et d'étude des plantes médicinales -IMPM-cameroun
Koulla-Shiro, S.
Ngassam, P.
Adiogo, D.
Njine, T.
Ndumbe, P.
Language :
English
Title :
Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon
Pfaller, M.A., Jones, R.N., Marshall, S.A., Coffman, B.L., Hollis, R.J., Edmond, M.B., Inducible AmpC β-lactamase producing Gram-negative bacilli from blood stream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE) (1997) Diagn Microbiol Infect Dis, 28, pp. 211-219
Archibald, L., Phillips, L., Monnet, D., Mac Govan, J.E., Tenover Jr., F., Gaynes, R., Antimicrobial resistance from inpatients and outpatients in the United States. Increasing importance of the intensive care unit (1997) Clin Infect Dis, 24, pp. 211-215
Bergone-Berezin, E., Decré, D., Joly-Guilou, M.L., Opportunistic nosocomial multiply resistant bacterial, infections- their treatment and prevention (1993) J Antimicrob Chemother, 32, pp. 39-47
Bryce, E.A., Smith, J.A., Focused microbiological surveillance and Gram-negative β-lactamase-mediated resistance in an intensive care unit (1995) Infect Control Hosp Epidemiol, 16, pp. 331-334
Ho, P.L., Yuen, K.Y., Yan, W.C., Wong Sai-Yin, S., Luk, W.K., Changing patterns of susceptibilities of blood, urinary and respiratory pathogens in Hong Kong (1995) Hosp Infect, 31, pp. 305-317
O'Brien, T.F., The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally (1997) Clin Infect Dis, 24 (SUPPL. 1), pp. S2-S8
Farmer III, J.J., Kelly, M.T., Enterobacteriaceae (1991) Manual of Clinical Microbiology, pp. 360-383. , Lenette EH, Balows A, Hausler WJ, Shadomy HJ, editors. Washington, DC: American Society for Microbiology
(1997) Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2 A6 (M100-S7), , Wayne, PA: National Committee for Clinical Laboratory Standards
Livermore, D.M., β-lactamases in laboratory and clinical resistance (1995) Clin Microbiol Rev, 8, pp. 557-584
Talarmin, A., Nizon, J.Y., Cavallo, J.D., Pseudomonas aeruginosa et β-lactamines: Mécanisme de résistance et conséquences thérapeutiques (1996) Méd Armées, 24, pp. 35-39
Jarlier, V., Nicolas, M.H., Fournier, G., Philippon, A., Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns (1988) Rev Infect Dis, 10, pp. 867-878
Gangoué Piéboji, J., (2000) Resistance des Bacilles à Gram Négatif aux Antibiotiques: Prévalence et Caractérisation des β-Lactamases à Spectre Élargi à l'Hôpital Central de Yaoundé, p. 210. , Thèse de Doctorat de 3e cycle, Université de Yaoundé I
Lamikamra, A., Ndep, R.B., Trimethoprim resistance in urinary tract pathogens in two Nigerian hospitals (1989) J Antimicrob Chemother, 23, pp. 151-154
Philippon, A., Arlet, G., Lagrange, P.H., Origin and impact of plasmid-mediated extended-spectrum β-lactamases (1994) Eur J Clin Microbiol Infect Dis, 13, pp. S1-S13
Huovinen, P., Increases in rates of resistance to trimethoprim (1997) Clin Infect Dis, 24, pp. S63-S66
Pfaller, M.A., Jones, R.N., Doern, G.V., Kugler, K., Bacterial pathogens isolated from patients with blood stream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997) (1998) Antimicrob Agents Chemother, 42, pp. 1762-1770
Koulla-Shiro, S., Boye, C.S., Dosso, M., (1998) Surveillance of Antimicrobial Susceptibility of Gram Negative Pathogens Responsible for Nosocomial Infections in West Africa (Abstract Number E-95), p. 197. , San Diego, California: 42nd ICAAC
Okeke, I.N., Lamikanra, A., Edelman, R., Socio-economic and behavioral factors leading to acquired bacterial, resistance to antibiotics in developing countries (1999) Emerg Infect Dis, 5, pp. 18-27
Eickhoff, T.C., Antibiotics and nosocomial infections (1992) Hospital Infections, pp. 245-264. , Bennett JV, Brachman PS, editors. Boston: Brown & Co
Rice, L.B., Willey, S.H., Papanicolaou, G.A., Eliopoulos, G.M., Moellering, R.C., Jacoby, G.A., Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility (1990) Antimicrob Agents Chemother, 34, pp. 2193-2199
Monnet, D.L., Archibald, L.K., Phillips, L., Tenover, F.C., McGowan, J.E., Gaynes, R.P., Antimicrobial use and resistance in eight US hospitals: Complexities of analysis and modeling (1998) Infect Control Hosp Epidemiol, 19, pp. 388-394
Edgeworth, J.D., Treacher, D.F., Eykyn, S.J., A 25-year study of nosocomial bacteremia in an adult intensive care unit (1999) Crit Care Med, 27, pp. 1421-1428
Kolar, M., Urbanek, K., Latal, T., Antibiotic selective pressure and development of bacterial resistance (2001) Int J Antimicrob Agents, 17, pp. 357-363
Lesch, C.A., Itokazu, G.S., Danziger, L.H., Weinstein, R.A., Multi-hospital analysis of antimicrobial usage and resistance trends (2001) Diagn Microbiol Infect Dis, 41, pp. 149-154
Huovinen, P., Sundström, L., Swedberg, G., Sköd, O., Trimethoprim and sulfonamide resistance (1995) Antimicrob Agents Chemother, 39, pp. 279-289
